Limited evidence suggests metformin might be beneficial to reduce head and neck cancer risk and increase overall survival, while any benefit with anti-inflammatory drugs is inconsistent

Publication date: Available online 20 August 2019Source: Journal of Evidence Based Dental PracticeAuthor(s): Analia Veitz-Keenan, Thamar Delia Silvestre Calle, Marco Bergamini
Source: Journal of Evidence Based Dental Practice - Category: Dentistry Source Type: research